June 29, 2021

Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth

ADELAIDE, AUS, June 28, 2021 – (ACN Newswire) – Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced…

June 28, 2021

Avance Clinical任命亚洲生物科技公司专家协助其亚太地区业务的增长

ADELAIDE, AUS, Jun 28, 2021 – (亚太商讯 via SEAPRWire.com) – 澳大利亚领先的国际生物技术 CRO 和 Frost & Sullivan 亚太 CRO 市场领…

June 4, 2021

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

ADELAIDE, AUS, Jun 4, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

May 27, 2021

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

ADELAIDE, AUS, May 27, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

May 7, 2021

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

ADELAIDE, AUS, May 7, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

April 25, 2021

Avance Clinical受邀发表“分散试验–不再回头” 适用于Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 – (亚太商讯 via SEAPRWire.com) – 澳大利亚领先的生物技术CRO和Frost＆Sullivan亚太CRO市场领导奖获得者Avance Cli…

April 22, 2021

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

March 12, 2021

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

ADELAIDE, AU, Mar 12, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership…

March 12, 2021

Avance临床客户Atossa Therapeutics宣布了第一阶段临床研究的最终结果，该研究表明针对COVID-19研发的AT-301鼻喷雾剂的安全性和耐受性

ADELAIDE, AU, Mar 12, 2021 – (亚太商讯 via SEAPRWire.com) – 澳大利亚领先的生物技术CRO和Frost＆Sullivan亚太CRO市场领导奖获得者Avance Cli…

February 26, 2021

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner,…

October 30, 2020

Avance Clinical Wins MasterControl 2020 Innovation Excellence Award

ADELAIDE, AU, Oct 30, 2020 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award…

October 28, 2020

Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma – announced at Bio-Europe 2020

BIO-Europe, Munich, Oct 28, 2020 – (ACN Newswire) – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia…